Lower gastrointestinal bleeding
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Synonyms and keywords: LIGB; Lower GI bleed; Acute lower gastrointestinal bleeding; Intestinal bleeding; Lower gastrointestinal hemorrhage
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Lower gastrointestinal bleeding is defined as blood loss originating distal to the ligament of Treitz. It accounts for 24% to 33% of all hospital admissions for gastrointestinal bleeding and is responsible for 1% of hospital admissions in the United States. It can present with frank blood loss per rectum or may be occult in nature, presenting with anemia. Bleeding can vary in severity from passage of small amounts of blood to massive life-threatening hemorrhage. Acute LGIB is described as bleeding of recent onset, which may result in hemodynamic instability and need for blood transfusion. Most commonly originates in the colon or ano–rectum; only 5% arise in the small bowel. Etiologies vary among adult, elderly, and pediatric populations. Ninety percent of lower gastrointestinal bleeding stop spontaneously; however, the underlying etiology needs to be diagnosed and treated accordingly. Overall mortality is less than 4%, but may be higher in elderly populations and in those with comorbid disease. Even bleeding of moderate rate can have significant sequel in a group of patients with the comorbid disease. A thorough history and detailed examination are essential steps in establishing the cause and the source of bleeding. Patients with severe bleeding or hemodynamic disturbance require hospitalization and urgent investigation. It is essential to distinguish between lower gastrointestinal bleeding and brisk upper gastrointestinal bleeding as they can present with similar symptoms. Treatment depends on the cause and the severity of the bleeding.
Historical Perspective
Roman encyclopedist, Aulus Cornelius Celsus, was the first to describe band ligation treatment for hemorrhoidal bleeding. In the 1700s, Alexis Littre described the association between diverticular diseases and bleeding. In 1885, Allchin gave a detailed description of ulcerative colitis which can present with bleeding. Until 1967, mesenteric ischemia was a diagnostic dilemma. In 1887, Welch proposed that ischemic bowel changes occur secondary to 80% stenosis of superior mesenteric artery (SMA) resulting in bleeding as a complication.
Classification
Lower gastrointestinal bleeding may be classified based on the severity of bleeding into occult, moderate and severe bleeding.
Pathophysiology
Superior mesenteric artery and inferior mesenteric artery are the two major blood vessels that supply lower gastrointestinal tract. Disruption of this blood vessel junction by any of the disease process results in bleeding. Diverticulosis is the most common etiology of lower GI bleeding accounting for 30% of all cases, followed by ano-rectal disease, ischemia of bowel, inflammatory bowel disease (IBD), neoplasia, and arteriovenous (AV) malformations. The characteristic gross and microscopic findings of lower gastrointestinal tracts depends upon the underlying pathology.
Causes
Common causes of lower gastrointestinal tract bleeding include diverticulosis, angiodysplasia, ischemic colitis, colorectal cancer, anorectal diseases, infectious colitis and inflammatory bowel disease. Less common causes of lower gastrointestinal tract include colonic polyps, radiation proctitis, and rectal varices.
Differentiating lower gastrointestinal bleeding from Other Diseases
Several diseases present with lower gastrointestinal bleeding and must be differentiated from each other. The common diseases responsible for lower GI bleeding include diverticulosis, angiodysplasia, hemorrhoids, anal fissures, mesenteric Ischemia, ischemic colitis, inflammatory bowel disease, and colo-rectal carcinoma.
Epidemiology and Demographics
The prevalence of lower gastrointestinal bleeding is approximately 20 per 100,000 population in the United States. Lower gastrointestinal bleed is more common in men than women.
Risk Factors
Common risk factors in the development of lower GI bleeding include advancing age, previous history of gastrointestinal bleed, chronic constipation, hematologic disorders, anticoagulants medications, non-steroidal anti-inflammatory drugs, and human immunodeficiency virus infection.
Screening
There is insufficient evidence to recommend routine screening for lower gastrointestinal bleeding.
Natural History, Complications, and Prognosis
If left untreated 90% of the time lower gastrointestinal bleeding is usually self-limited. However, massive blood loss can result in a severe drop in blood pressure resulting in decreased blood supply to organ systems leading to death. Hypovolemic shock and symptomatic anemia are the most common direct complications of LGIB. Prognosis is generally good, and the 1-year mortality rate of patients with lower gastrointestinal bleeding is less than four percent.
Diagnosis
Diagnostic Study of Choice
Colonoscopy is the gold standard test for the diagnosis of lower gastrointestinal bleeding. However, Endoscopy is the investigation of choice in cases of lower gastrointestinal bleeding caused by ischemic colitis or colonoscopy is unequivocal.
History and Symptoms
The hallmark symptom of LGIB is bleeding per rectum or frank blood in stools. The presentation of associated symptoms depends upon the source of the bleeding and underlying etiology. Associated symptoms of lower gastrointestinal bleeding include fever, abdominal pain, bloody diarrhea, dehydration, history of constipation, and hypotension in severe cases, and weight loss. A detailed description of the nature of the blood loss can also help in pinpointing the likely source of bleeding.
Physical Examination
The most common physical examination finding is the passage of frank blood per rectum (hematochezia).
Laboratory Findings
The essential blood work in diagnosing lower gastrointestinal bleeding includes a complete blood count, renal function and liver function tests, and coagulation studies. Although not diagnostic, a blood type and crossmatch should be done in patients who present with life-threatening bleeding.
Electrocardiogram
There are no specific ECG findings associated with lower gastrointestinal bleeding. However, an electrocardiogram is be performed in order to exclude arrhythmia and cardiac causes of hypotension (following acute MI).
X-ray
There are no abdominal x-ray findings associated with lower gastrointestinal bleeding. However, an x-ray may be helpful in the diagnosing the complications of underlying disease.
Ultrasound
There are no specific ultrasound findings associated with lower gastrointestinal bleeding. However, ultrasound can be useful in diagnosing various etiology or conditions responsible for lower gastrointestinal bleeding.
CT scan
Helical CT scanning of the abdomen and pelvis is recommended when a routine workup fails to determine the cause of active gastrointestinal bleeding. Findings of helical CT scan in lower gastrointestinal bleeding include vascular extravasation of the contrast medium, contrast enhancement of the bowel wall, thickening of the bowel wall, hyperdensity of the peri-bowel fat, and vascular dilatations.
MRI
There are no MRI findings associated with lower gastrointestinal bleeding.
Other Imaging Findings
Other imaging studies include angiography and radionuclide imaging that can be helpful in diagnosing lower gastrointestinal bleeding.
Other Diagnostic Studies
Nasogastric tube lavage may be helpful in the diagnosis of lower gastrointestinal bleeding. Nasogastrictube lavage helps in differentiating lower gastrointestinal bleeding from upper gastrointestinal bleeding. Evidence of old (brown colored or ‘coffee grounds’) or fresh blood on NGT aspirate documents presence of upper gastrointestinal bleeding. Evidence of bilious material rules out bleeding distal to the pylorus.
Treatment
Medical Therapy
The aims of treatment are to resuscitate the patient, identify the source of blood loss and stop any ongoing bleeding, and reduce the risk of a recurrent bleed. It is essential to identify patients who are high risk. This would include elderly patients; those with severe ongoing bleeding or recurrent bleeding; and patients with multiple comorbid conditions, in particular, those patients with cardiac, renal, respiratory, and liver disease. Treatment depends on the mode of presentation, the severity of the bleed, and the underlying pathology. Bleeding points can be treated with endoscopy, interventional radiology, or surgery. After identification of the source of bleeding using endoscopy, therapeutic options include monopolar or bipolar diathermy, argon plasma coagulation (APC), epinephrine injections, and endoloops and hemoclips, used individually or in combination. These methods can be used to treat many of the causes of LGIB, including diverticular bleeding, angiodysplasia, radiation proctitis, and post-polypectomy bleeding interventional radiology can be used to visualize a bleeding vessel and to stop the bleeding through embolization of the vessel. Surgery may be required if less invasive measures cannot be applied or are not effective. Pharmacotherapy is only used as an adjuvant therapy for all patients with LGIB. Epinephrine is used alone or in conjunction with other surgical techniques to treat a variety of causes of LGIB.
Surgery
Emergency surgery may be needed to control bleeding in about 10% to 25% of patients in whom nonoperative management is unsuccessful or unavailable. The various endoscopic interventions employed in the management of lower gastrointestinal bleeding include argon plasma coagulation, bipolar or Heater probe, endoloops and hemoclips, and interventional radiology.
Primary Prevention
Effective measures for the primary prevention of lower GI bleeding include techniques to prevent the related conditions. Promoting a healthy lifestyle by eating a healthy diet, exercising lightly, and avoiding alcohol and tobacco can reduce the risk associated conditions.
Secondary Prevention
Secondary primary preventive measures of lower gastrointestinal bleeding is similar to primary prevention.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Roman encyclopedist Aulus Cornelius Celsus was the first to describe band ligation treatment for hemorrhoidal bleeding. In the 1700s, Alexis Littre was the first to describe the association between diverticular diseases and bleeding. In 1885, Allchin gave a detailed description of ulcerative colitis along bleeding.Until 1967, mesenteric ischemia was a diagnostic dilemma. In 1887, Welch proposed that ischemic bowel changes occur secondary to 80% stenosis of superior mesenteric artery (SMA) resulting in bleeding as a complication.
Historical perspective
- Roman encyclopedist Aulus Cornelius Celsus was the first to describe band ligation treatment for hemorrhoidal bleeding.
- In the 1700s, Alexis Littre was the first to describe diverticular diseases, where he reported “diverticular hernia” without explaining it.[1]
- In 1885, Allchin gave a detailed description of ulcerative colitis for the first time.[2]
- Until 1967, mesenteric ischemia was a diagnostic dilemma.[3]
- In 1887, Welch proposed that ischemic bowel changes occur secondary to 80% stenosis of superior mesenteric artery (SMA).[4]
- In 1849, Jean Cruveilheir, a French anatomist, was the first to describe in detail the diverticular herniations through the muscular wall of the colon.
- In 1913 Giovanni Battista Morgagni (1682-1771) and Scottish physician T. Kennedy Dalziel described inflammatory bowel diseases in detail for the first time.
- In 1936, Dunphy was the first one to establish an association between mesenteric artery occlusion and gut infarction.
- In 1963, Boley was the first to describe ischemic colitis as a vascular occlusion of the colon.
References
- ↑ Matrana MR, Margolin DA (2009). “Epidemiology and pathophysiology of diverticular disease”. Clin Colon Rectal Surg. 22 (3): 141–6. doi:10.1055/s-0029-1236157. PMC 2780269. PMID 20676256.
- ↑ De Dombal FT (1968). “Ulcerative colitis: definition, historical background, aetiology, diagnosis, naturel history and local complications”. Postgrad Med J. 44 (515): 684–92. PMC 2466707. PMID 5705372.
- ↑ Harper DR, Buist TA (1978). “Selective angiography in acute mid-gut ischaemia”. Gut. 19 (2): 132–6. PMC 1411821. PMID 631629.
- ↑ Yamada, Kei; Saeki, Mitsuaki; Yamaguchi, Toshio; Taira, Makiko; Ohyama, Yukio; Ashida, Hiroshi; Sakuyama, Keiko; Ishikawa, Toru (1998). “Acute mesenteric ischemia”. Clinical Imaging. 22 (1): 34–41. doi:10.1016/S0899-7071(97)00071-5. ISSN 0899-7071.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Lower gastrointestinal bleeding can be classified into occult, moderate and severe bleeding based on the severity of bleeding.
Classification
Lower GI bleeding can be classified into 3 groups based on the severity of bleeding:[1][2][3][4][5][6]
- Occult lower GI bleeding
- Moderate lower GI bleeding
- Severe lower GI bleeding
| Severe lower GI bleeding | Moderate lower GI bleeding | Occult lower GI bleeding | |
|---|---|---|---|
| Age | > 65 years | Occur at any age | Any age |
| Presenting symptoms | Hematochezia or bright red blood per rectum. | Hematochezia or melena | Symptoms of anemia (fatigue, tiredness) |
| Hemodynamics | Unstable | Stable | Stable |
| Lab findings | Hemoglobin equal to or less than 6 g/dl. | Microcytic anemia | Microcytic hypochromic anemia due to chronic blood loss. |
| Differential |
References
- ↑ Lee EW, Laberge JM (2004). “Differential diagnosis of gastrointestinal bleeding”. Tech Vasc Interv Radiol. 7 (3): 112–22. PMID 16015555.
- ↑ Raju GS, Gerson L, Das A, Lewis B (2007). “American Gastroenterological Association (AGA) Institute medical position statement on obscure gastrointestinal bleeding”. Gastroenterology. 133 (5): 1694–6. doi:10.1053/j.gastro.2007.06.008. PMID 17983811.
- ↑ Rockey DC (2010). “Occult and obscure gastrointestinal bleeding: causes and clinical management”. Nat Rev Gastroenterol Hepatol. 7 (5): 265–79. doi:10.1038/nrgastro.2010.42. PMID 20351759.
- ↑ Rockey DC (2005). “Gastrointestinal bleeding”. Gastroenterol. Clin. North Am. 34 (4): 581–8. doi:10.1016/j.gtc.2005.08.002. PMID 16303571.
- ↑ Green BT, Rockey DC (2003). “Acute gastrointestinal bleeding”. Semin. Gastrointest. Dis. 14 (2): 44–65. PMID 12889580.
- ↑ Rockey DC (1999). “Occult gastrointestinal bleeding”. N. Engl. J. Med. 341 (1): 38–46. doi:10.1056/NEJM199907013410107. PMID 10387941.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Superior mesenteric artery and inferior mesenteric artery are the two major blood vessels that supply lower gastrointestinal tract. Disruption of blood vessel junction, formed by these two vessels, by any of the disease process results in bleeding. Diverticulosis is the most common etiology of lower GI bleeding accounting for 30% of all cases, followed by ano-rectal disease, ischemia of bowel, inflammatory bowel disease (IBD), neoplasia, and arteriovenous (AV) malformations. The characteristic gross and microscopic findings of lower gastrointestinal tracts depends upon the underlying pathology.
Pathophysiology
Blood supply
- Superior mesenteric artery and inferior mesenteric artery are the two major blood vessels that supply lower gastrointestinal tract.[1][2][3]
- The superior mesenteric artery and inferior mesenteric artery are interconnected through a branch of anastomosis between various branches which are collectively called as marginal artery of Drummond.
- This vascular arcade runs in the mesentery close to the bowel.
| Lower GI Tract | Arterial Supply | Venous Drainage | |
|---|---|---|---|
| Midgut | |||
| Hindgut |
|
||
| ɸ -Except lower rectum, which drains into the systemic circulation. | |||

Source: By Anpol42 (Own work) [CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons
Pathogenesis
The pathogenesis of lower gastrointestinal bleeding can be discussed based on the etiology. Diverticulosis is the most common etiology of lower GI bleeding accounting for 30% of all cases, followed by anorectal disease, ischemia, inflammatory bowel disease (IBD), neoplasia, and arteriovenous (AV) malformations.
- Diverticulosis
- The colonic wall weakens with age and results in the formation of sac-like protrusions known as diverticula.[4][5][6][7]
- These protrusions generally occur at the junction of blood vessel penetrating through the mucosa and circular muscle fibers of the colon.
- Hemorrhage results from rupture of the intramural branches (vasa recta) of the marginal artery at the dome of a diverticulum and can give rise to a massive, life-threatening LGIB.

Source:By Anpol42 (Own work) [CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons
- Anorectal disease
- Hemorrhoids are defined as swelling and inflammation of veins in the rectal and anal region
- Hemorrhoids can be either internal or external based on their relation to dentate line.
- The first step in the pathogenesis of either type of hemorrhoids is weakening of the surrounding connective tissue and vein wall.[8][9][8]
- Weakening of blood vessels can result in bleeding under pressure.
- An anal fissure can be defined as disruption or tear in the mucosal surface of the skin.
- During defecation, due to increased pressure which can exaggerate the tears may present as bright red rectal bleeding with severe periodic pain.[10]
- Mesenteric ischemia results when there is inadequate blood supply at the level of the small intestine.[11][12][13][14]
- 2 or more vessels (celiac, SMA, or IMA) must be involved for bleeding to occur.
- Decreased blood supply can occur due to obstruction of blood vessel either by emobolus or due to vasoconstriction effect of drugs.
- Decreased blood supply initiates necrosis of mucosal surface of intestine.
- unopposed blood deprivation leads to trans-mural necrosis and ultimately sloughing of the tissues with associated bleeding.
- Ischemic colitis is a condition in which injury of the large intestine results from decreased blood supply.[15][16][17]
- The colon is most commonly involved due the presence of water shed areas ( splenic flexure and hepatic flexure).
- Similar to mesentric ischemia bleeding occurs due to necrosis and sloughing of mucosal membrane.
- Inflammatory Bowel Disease[18][19]
- Crohn’s disease
- In Crohn’s disease, T cell activation stimulates interleukin (IL)-12 and tumor necrosis factor (TNF)-α, resulting in chronic inflammation and tissue injury.[20][21][22][23][24][25]
- TNF-alpha induces expression of adhesion factors that allow for inflammatory cells to infiltrate and activates macrophages resulting in granuloma formations
- The inflammatory response invades through the entire thickness of the bowel wall weakening the surrounding blood vessels resulting in bleeding.
- Crohn’s disease
- Ulcerative colitis
- In ulcerative colitis, T cells, cytotoxic to the colonic epithelium, accumulate in the lamina propria, accompanied by B cells that secrete immunoglobulin G (IgG) and IgE.[23][26][27][28]
- This results in inflammation of the crypts of Lieberkuhn, with abscesses and pseudopolyps along with
- rupturing of minute blood vessels in mucosa resulting in bleeding.
- Ulcerative colitis
- Neoplasia
- Colon cancer arises mostly due to sporadic mutations that originates from the epithelial cells of colon or rectum.
- Genetic instability/mutation results in epigenetic alteration, chronic inflammation, oxidative stress, and intestinal microbiota.[29][30][31]
- As tumor tends to grow slowly it invades the surrounding tissue disrupting the normal blood vessels along with it.
- This is responsible for slow occult bleeding that is found positive on FOBT.
- AV Malformation/Angiodysplasia
- In AV malformation abnormal connections occur between arteries and veins.[32][33][34][35][36]
- This connections results in blood flow from high pressure arteries to low pressure veins without buffering effects of capillaries.
- The lack of capillary buffers makes the vessels weak due to increased blood flow and ultimately bleeding.
- In Angiodysplasia, with age the connective tissue of the blood vessels become weak.
- With mild increase in pressure leads to disrupture of vessels leading to painless bleeding.
Associated Conditions
Other diseases that are commonly associated with lower gastrointestinal bleeding include:
- Aortoenteric fistula
- Abdominal aortic aneurysms
- Peutz-Jeghers syndrome
- Klippel-Trenaunay-Weber syndrome
- Hereditary hemorrhagic telangiectasia
- Neurofibromatosis
- Blue rubber bleb syndrome
Gross and Microscopic Pathology
| Disease | Gross Pathology | Microscopic Pathology |
|---|---|---|
| Diverticulosis[37] |
|
|
| Angiodysplasia[38] |
|
|
| Hemorrhoids[8] |
|
|
| Mesenteric ischemia [39] |
| |
| Ischemic colitis[39] |
|
|
| Crohn’s disease[40][41] |
|
|
| Ulcerative colitis[42] |
|
|
References
- ↑ Geboes K, Geboes KP, Maleux G (2001). “Vascular anatomy of the gastrointestinal tract”. Best Pract Res Clin Gastroenterol. 15 (1): 1–14. doi:10.1053/bega.2000.0152. PMID 11355897.
- ↑ Granger DN, Holm L, Kvietys P (2015). “The Gastrointestinal Circulation: Physiology and Pathophysiology”. Compr Physiol. 5 (3): 1541–83. doi:10.1002/cphy.c150007. PMID 26140727.
- ↑ “The Gastrointestinal Circulation – NCBI Bookshelf”.
- ↑ Hobson KG, Roberts PL (2004). “Etiology and pathophysiology of diverticular disease”. Clin Colon Rectal Surg. 17 (3): 147–53. doi:10.1055/s-2004-832695. PMC 2780060. PMID 20011269.
- ↑ Maykel JA, Opelka FG (2004). “Colonic diverticulosis and diverticular hemorrhage”. Clin Colon Rectal Surg. 17 (3): 195–204. doi:10.1055/s-2004-832702. PMC 2780065. PMID 20011276.
- ↑ Comparato G, Pilotto A, Franzè A, Franceschi M, Di Mario F (2007). “Diverticular disease in the elderly”. Dig Dis. 25 (2): 151–9. doi:10.1159/000099480. PMID 17468551.
- ↑ Matrana MR, Margolin DA (2009). “Epidemiology and pathophysiology of diverticular disease”. Clin Colon Rectal Surg. 22 (3): 141–6. doi:10.1055/s-0029-1236157. PMC 2780269. PMID 20676256.
- ↑ 8.0 8.1 8.2 Lohsiriwat V (2012). “Hemorrhoids: from basic pathophysiology to clinical management”. World J. Gastroenterol. 18 (17): 2009–17. doi:10.3748/wjg.v18.i17.2009. PMC 3342598. PMID 22563187.
- ↑ Sanchez C, Chinn BT (2011). “Hemorrhoids”. Clin Colon Rectal Surg. 24 (1): 5–13. doi:10.1055/s-0031-1272818. PMC 3140328. PMID 22379400.
- ↑ Holland RA, Rimes AF, Comis A, Tyndale-Biscoe CH (1988). “Oxygen carriage and carbonic anhydrase activity in the blood of a marsupial, the Tammar wallaby (Macropus eugenii), during early development”. Respir Physiol. 73 (1): 69–86. PMID 3140330.
- ↑ Krupski WC, Selzman CH, Whitehill TA (1997). “Unusual causes of mesenteric ischemia”. Surg. Clin. North Am. 77 (2): 471–502. PMID 9146726.
- ↑ Walker TG (2009). “Mesenteric ischemia”. Semin Intervent Radiol. 26 (3): 175–83. doi:10.1055/s-0029-1225662. PMC 3036494. PMID 21326562.
- ↑ Berland T, Oldenburg WA (2008). “Acute mesenteric ischemia”. Curr Gastroenterol Rep. 10 (3): 341–6. PMID 18625147.
- ↑ Mastoraki A, Mastoraki S, Tziava E, Touloumi S, Krinos N, Danias N, Lazaris A, Arkadopoulos N (2016). “Mesenteric ischemia: Pathogenesis and challenging diagnostic and therapeutic modalities”. World J Gastrointest Pathophysiol. 7 (1): 125–30. doi:10.4291/wjgp.v7.i1.125. PMC 4753178. PMID 26909235.
- ↑ FitzGerald JF, Hernandez Iii LO (2015). “Ischemic colitis”. Clin Colon Rectal Surg. 28 (2): 93–8. doi:10.1055/s-0035-1549099. PMC 4442720. PMID 26034405.
- ↑ Theodoropoulou A, Koutroubakis IE (2008). “Ischemic colitis: clinical practice in diagnosis and treatment”. World J. Gastroenterol. 14 (48): 7302–8. PMC 2778113. PMID 19109863.
- ↑ Rania H, Mériam S, Rym E, Hyafa R, Amine A, Najet BH, Lassad G, Mohamed TK (2014). “Ischemic colitis in five points: an update 2013”. Tunis Med. 92 (5): 299–303. PMID 25504381.
- ↑ Kim DH, Cheon JH (2017). “Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies”. Immune Netw. 17 (1): 25–40. doi:10.4110/in.2017.17.1.25. PMC 5334120. PMID 28261018.
- ↑ Hendrickson BA, Gokhale R, Cho JH (2002). “Clinical aspects and pathophysiology of inflammatory bowel disease”. Clin. Microbiol. Rev. 15 (1): 79–94. PMC 118061. PMID 11781268.
- ↑ Woźniak-Parnowska W, Werakso B (1974). “[Comparative studies of microbiological purity of ointments by the direct culture method and use of membrane filters]”. Acta Pol Pharm (in Polish). 31 (6): 819–23. PMID 4447044.
- ↑ Mazal J (2014). “Crohn disease: pathophysiology, diagnosis, and treatment”. Radiol Technol. 85 (3): 297–316, quiz 317–20. PMID 24395894.
- ↑ Jewell DP (1989). “Aetiology and pathogenesis of ulcerative colitis and Crohn’s disease”. Postgrad Med J. 65 (768): 718–9. PMC 2429831. PMID 2694136.
- ↑ 23.0 23.1 Sartor RB (2006). “Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis”. Nat Clin Pract Gastroenterol Hepatol. 3 (7): 390–407. doi:10.1038/ncpgasthep0528. PMID 16819502.
- ↑ Head K, Jurenka JS (2004). “Inflammatory bowel disease. Part II: Crohn’s disease–pathophysiology and conventional and alternative treatment options”. Altern Med Rev. 9 (4): 360–401. PMID 15656711.
- ↑ Zhang YZ, Li YY (2014). “Inflammatory bowel disease: pathogenesis”. World J. Gastroenterol. 20 (1): 91–9. doi:10.3748/wjg.v20.i1.91. PMC 3886036. PMID 24415861.
- ↑ Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017). “Ulcerative colitis”. Lancet. 389 (10080): 1756–1770. doi:10.1016/S0140-6736(16)32126-2. PMID 27914657.
- ↑ Farrell RJ, Peppercorn MA (2002). “Ulcerative colitis”. Lancet. 359 (9303): 331–40. doi:10.1016/S0140-6736(02)07499-8. PMID 11830216.
- ↑ Rönnblom LE, Janson ET, Perers A, Oberg KE, Alm GV (1992). “Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment”. Clin. Exp. Immunol. 89 (3): 330–5. PMC 1554468. PMID 1516252.
- ↑ Itzkowitz S (2003). “Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice”. J. Clin. Gastroenterol. 36 (5 Suppl): S70–4, discussion S94–6. PMID 12702969.
- ↑ Ullman TA, Itzkowitz SH (2011). “Intestinal inflammation and cancer”. Gastroenterology. 140 (6): 1807–16. doi:10.1053/j.gastro.2011.01.057. PMID 21530747.
- ↑ Kraus S, Arber N (2009). “Inflammation and colorectal cancer”. Curr Opin Pharmacol. 9 (4): 405–10. doi:10.1016/j.coph.2009.06.006. PMID 19589728.
- ↑ Foutch PG (1993). “Angiodysplasia of the gastrointestinal tract”. Am. J. Gastroenterol. 88 (6): 807–18. PMID 8389094.
- ↑ Dodda G, Trotman BW (1997). “Gastrointestinal angiodysplasia”. J Assoc Acad Minor Phys. 8 (1): 16–9. PMID 9048468.
- ↑ Kheterpal S (1991). “Angiodysplasia: a review”. J R Soc Med. 84 (10): 615–8. PMC 1295562. PMID 1744847.
- ↑ Athanasoulis CA, Galdabini JJ, Waltman AC, Novelline RA, Greenfield AJ, Ezpeleta ML (1977). “Angiodysplasia of the colon: a cause of rectal bleeding”. Cardiovasc Radiol. 1 (1): 3–13. PMID 311247.
- ↑ Sami SS, Al-Araji SA, Ragunath K (2014). “Review article: gastrointestinal angiodysplasia – pathogenesis, diagnosis and management”. Aliment. Pharmacol. Ther. 39 (1): 15–34. doi:10.1111/apt.12527. PMID 24138285.
- ↑ West AB, Losada M (2004). “The pathology of diverticulosis coli”. J. Clin. Gastroenterol. 38 (5 Suppl 1): S11–6. PMID 15115923.
- ↑ Stamm B, Heer M, Bühler H, Ammann R (1985). “Mucosal biopsy of vascular ectasia (angiodysplasia) of the large bowel detected during routine colonoscopic examination”. Histopathology. 9 (6): 639–46. PMID 4029903.
- ↑ 39.0 39.1 Mitsudo S, Brandt LJ (1992). “Pathology of intestinal ischemia”. Surg. Clin. North Am. 72 (1): 43–63. PMID 1731389.
- ↑ Price AB, Morson BC (1975). “Inflammatory bowel disease: the surgical pathology of Crohn’s disease and ulcerative colitis”. Hum. Pathol. 6 (1): 7–29. PMID 1089084.
- ↑ Wright CL, Riddell RH (1998). “Histology of the stomach and duodenum in Crohn’s disease”. Am. J. Surg. Pathol. 22 (4): 383–90. PMID 9537465.
- ↑ DeRoche TC, Xiao SY, Liu X (2014). “Histological evaluation in ulcerative colitis”. Gastroenterol Rep (Oxf). 2 (3): 178–92. doi:10.1093/gastro/gou031. PMC 4124271. PMID 24942757.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Common causes of lower gastrointestinal tract bleeding include diverticulosis, angiodysplasia, ischemic colitis, colorectal cancer, anorectal diseases, infectious colitis and inflammatory bowel disease. Less common causes of lower gastrointestinal tract include colonic polyps, radiation proctitis, and rectal varices.
Causes
Common causes
Common causes of lower gastrointestinal bleeding inclue:[1][2][3][4][5][6][7][8][9][2][10]
- Colonic diverticulosis
- Vascular ectasias (angiodysplasias/angioectasias)
- Iatrogenic
- Ischemic colitis
- Colorectal malignancy
- Anorectal abnormalities
- Inflammatory bowel disease (IBD)
- Infectious colitis
Less common causes
Less common causes of lower gastrointestinal bleeding include:
- Colonic polyps
- Radiation proctitis
- Rectal varices
- Meckel diverticulum
- Intussusception
- Henoch-Schönlein purpura (HSP)
References
- ↑ Bresci G (2009). “Occult and obscure gastrointestinal bleeding: Causes and diagnostic approach in 2009”. World J Gastrointest Endosc. 1 (1): 3–6. doi:10.4253/wjge.v1.i1.3. PMC 2999069. PMID 21160643.
- ↑ 2.0 2.1 Ghassemi KA, Jensen DM (2013). “Lower GI bleeding: epidemiology and management”. Curr Gastroenterol Rep. 15 (7): 333. doi:10.1007/s11894-013-0333-5. PMC 3857214. PMID 23737154.
- ↑ Hillemeier C, Gryboski JD (1984). “Gastrointestinal bleeding in the pediatric patient”. Yale J Biol Med. 57 (2): 135–47. PMC 2589822. PMID 6382833.
- ↑ Clouse RE, Costigan DJ, Mills BA, Zuckerman GR (1985). “Angiodysplasia as a cause of upper gastrointestinal bleeding”. Arch. Intern. Med. 145 (3): 458–61. PMID 3872107.
- ↑ Rockey DC (2010). “Occult and obscure gastrointestinal bleeding: causes and clinical management”. Nat Rev Gastroenterol Hepatol. 7 (5): 265–79. doi:10.1038/nrgastro.2010.42. PMID 20351759.
- ↑ “Hematemesis, Melena, and Hematochezia – Clinical Methods – NCBI Bookshelf”.
- ↑ Navuluri R, Kang L, Patel J, Van Ha T (2012). “Acute lower gastrointestinal bleeding”. Semin Intervent Radiol. 29 (3): 178–86. doi:10.1055/s-0032-1326926. PMC 3577586. PMID 23997409.
- ↑ Feinman M, Haut ER (2014). “Lower gastrointestinal bleeding”. Surg. Clin. North Am. 94 (1): 55–63. doi:10.1016/j.suc.2013.10.005. PMID 24267497.
- ↑ Zuccaro G (2008). “Epidemiology of lower gastrointestinal bleeding”. Best Pract Res Clin Gastroenterol. 22 (2): 225–32. doi:10.1016/j.bpg.2007.10.009. PMID 18346680.
- ↑ Zahmatkeshan M, Fallahzadeh E, Najib K, Geramizadeh B, Haghighat M, Imanieh MH (2012). “Etiology of lower gastrointestinal bleeding in children:a single center experience from southern iran”. Middle East J Dig Dis. 4 (4): 216–23. PMC 3990129. PMID 24829660.
Differentiating Lower gastrointestinal bleeding from other Diseases
[[Image:Home_logo1.png|right|250px|link=

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Several diseases present with lower gastrointestinal bleeding and must be differented from each other. The common diseases responsible for lower GI bleeding inlcude diverticulosis, angiodysplasia, hemorrhoids, anal fissures, mesenteric Ischemia, ischemic colitis, inflammatory bowel disease, and colorectal carcinoma.
Differentiating Lower gastrointestinal bleeding from other Diseases
Several diseases present with lower gastrointestinal bleeding and must be differented from each other. The common diseases responsible for lower GI bleeding inlcude diverticulosis, angiodysplasia, hemorrhoids, anal fissures, mesenteric Ischemia, ischemic colitis, inflammatory bowel disease, and colorectal carcinoma.
| Disease | Symptoms | Other features | Diagnosis | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Abdominal pain | Rectal pain | Weightloss | Fever | Type of GI bleeding | Diarrhea | Constipation | Laboratory findings | Radio-Imaging findings | ||
| Diverticulosis | – | – | – | – | Red or maroon-colored blood | – | + |
|
Normal |
Globular outpouchings on CT scan |
| Angiodysplasia | – | – | – | – | Frank blood | – | – |
|
Normal | Normal |
| Hemorrhoids | – | + | – | – | Blood on tissues | – | + |
|
– | Tortuous dilated vessels on anoscopy |
| Anal fissures | – | + | – | – | Blood on tissues | – | + |
|
Normal except mild leucocytosis | Anoscopy |
| Mesenteric Ischemia | + | – | + | + | Frank blood | + | – |
|
| |
| Ischemic colitis | + | – | – | + | Frank blood | + | – | 3 phases
|
|
|
| Crohn’s disease | + | – | + | + | Blood mixed with stools | + | + | Extra intestinal manifestations |
| |
| Ulcerative colitis | + | + | + | + | Blood mixed with stools | + | + |
|
|
|
| Colon carcinoma | + | -† | + | + | Occult bleeding | + | +† | + FOBT (fecal occult blood test)
↑ CEA( and CA 19-9 |
||
The following table differentiates all the diseases presenting with abdominal pain and lower gastrointestinal bleeding.
Abbreviations: RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin, SMA= Superior mesenteric artery, SMV= Superior mesenteric vein, ECG= Electrocardiogram
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
The prevalence of lower gastrointestinal bleeding is approximately 20 per 100,000 population in the United States. Lower gastrointestinal bleed is more common in men than women.
Epidemiology
Prevalence
- The prevalence of lower gastrointestinal bleeding is approximately 20 per 100,000 population in the United States.[1][2]
Incidence
- The estimated annual incidence of lower GI bleeding is approximately 0.03% in the adult population as a whole.
- The overall incidence of lower GI bleeding is approximately 27 per 100,000 population in the United States.

Source: https://creativecommons.org/licenses/by-sa/4.0/
Demographics
Gender
- Lower gastrointestinal bleed (LGIB) is more common in men than women.[1]
Race
- There is no racial predilection to lower gastrointestinal bleeding.
Age
- LGIB is rare in children.
- The incidence of lower GI bleeding increases with age with a 200-fold increase from the second to eighth decades of life.

Source:https://creativecommons.org/licenses/by-sa/4.0/
References
- ↑ 1.0 1.1 Ghassemi KA, Jensen DM (2013). “Lower GI bleeding: epidemiology and management”. Curr Gastroenterol Rep. 15 (7): 333. doi:10.1007/s11894-013-0333-5. PMC 3857214. PMID 23737154.
- ↑ Zuccaro G (2008). “Epidemiology of lower gastrointestinal bleeding”. Best Pract Res Clin Gastroenterol. 22 (2): 225–32. doi:10.1016/j.bpg.2007.10.009. PMID 18346680.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Common risk factors in the development of lower GI bleeding include advancing age, previous history of gastrointestinal bleeding, chronic constipation, hematologic disorders, medications such as anticoagulants, non-steroidal anti-inflammatory drugs, and human immunodeficiency virus infection.
Risk Factors
Common risk factors in the development of lower GI bleeding include:[1][2][3][4]
- Advancing age
- Previous history of gastrointestinal bleed
- Chronic constipation
- Hematologic disorders
- Anticoagulants
- Non-steroidal anti-inflammatory drugs
- Human immunodeficiency virus infection
| Risk factor | Pathophysiology of bleeding |
| Chronic constipation | Results in colonic diverticula and predispose patients to anal fissures and hemorrhoid formation |
| Hematologic disorders | Deficiencies in clotting factors, such as factor VII and factor VIII, predispose to LGIB |
| Anticoagulants | Patients taking warfarin, heparin, aspirin, and platelet inhibitors are at increased risk of bleeding in general |
| Nonsteroidal anti-inflammatory drugs | NSAIDs cause ulceration in the terminal ileum and proximal colon, and can exacerbate IBD |
| Human immunodeficiency virus | In patients with HIV, bleeding is caused by opportunistic infections, cytomegalovirus colitis, Kaposi sarcoma, or lymphoma |
References
- ↑ Navuluri R, Kang L, Patel J, Van Ha T (2012). “Acute lower gastrointestinal bleeding”. Semin Intervent Radiol. 29 (3): 178–86. doi:10.1055/s-0032-1326926. PMC 3577586. PMID 23997409.
- ↑ Strate LL (2005). “Lower GI bleeding: epidemiology and diagnosis”. Gastroenterol. Clin. North Am. 34 (4): 643–64. doi:10.1016/j.gtc.2005.08.007. PMID 16303575.
- ↑ Ríos A, Montoya MJ, Rodríguez JM, Serrano A, Molina J, Ramírez P, Parrilla P (2007). “Severe acute lower gastrointestinal bleeding: risk factors for morbidity and mortality”. Langenbecks Arch Surg. 392 (2): 165–71. doi:10.1007/s00423-006-0117-6. PMID 17131153.
- ↑ Strate LL, Orav EJ, Syngal S (2003). “Early predictors of severity in acute lower intestinal tract bleeding”. Arch. Intern. Med. 163 (7): 838–43. doi:10.1001/archinte.163.7.838. PMID 12695275.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
There is insufficient evidence to recommend routine screening for lower gastrointestinal bleeding.
Screening
There is insufficient evidence to recommend routine screening for lower gastrointestinal bleeding.
References
Natural History, Complications, and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
If left untreated, lower gastrointestinal bleeding is usually self-limited (90% of the time bleeding stops on its own). Massive blood loss can result in a severe drop in blood pressure resulting in decreased blood supply to organ systems leading to death. Hypovolemic shock and symptomatic anemia are the most common direct complications of LGIB. Prognosis is generally good, and the 1-year mortality rate of patients with lower gastrointestinal bleeding is less than 3%.
Natural History, Complications, and Prognosis
Natural History
If left untreated, lower gastrointestinal bleeding is usually self-limited (90% of the time bleeding stops on its own). Massive blood loss can result in a severe drop in blood pressure resulting in decreased blood supply to organ systems leading to death. Chronic blood loss if left untreated results in anemia.[1]
Complications
Common complications of LGIB include:[2][3]
- Hypovolemic shock and symptomatic anemia are the most common direct complications of LGIB.
- Rebleeding following treatment is not uncommon.
- All treatment modalities have potential adverse affects:
- Endoscopy carries a risk of bowel perforation.
- Angiography and superselective embolization can result in bowel ischemia.
- Surgery is associated with the highest complication rates and should only be considered in patients who have ongoing bleeding that cannot be controlled by other methods.
Prognosis
- Prognosis is generally good, and the 1 year mortality rate of patients with lower gastrointestinal bleeding is approximately <3%.[4][5]
- With definitive intervention to treat or remove the source of blood loss, rebleeding rates are low.
- Without definitive treatment, rebleeding rates can be appreciable, as high as 38%.
References
- ↑ Waggershauser CH, Storr M (2016). “[Lower gastrointestinal bleeding]”. MMW Fortschr Med (in German). 158 (9): 50–1. doi:10.1007/s15006-016-8208-y. PMID 27155708.
- ↑ Navuluri R, Kang L, Patel J, Van Ha T (2012). “Acute lower gastrointestinal bleeding”. Semin Intervent Radiol. 29 (3): 178–86. doi:10.1055/s-0032-1326926. PMC 3577586. PMID 23997409.
- ↑ Chait MM (2010). “Lower gastrointestinal bleeding in the elderly”. World J Gastrointest Endosc. 2 (5): 147–54. doi:10.4253/wjge.v2.i5.147. PMC 2998909. PMID 21160742.
- ↑ Sanfilippo G, Patanè R, Fusto A, Passanisi G, Valenti R, Russo A (1986). “Endoscopic approach to childhood coeliac disease”. Acta Gastroenterol. Belg. 49 (4): 401–8. PMID 3577609.
- ↑ “Lower gastrointestinal tract bleeding: a problem based approach – Surgical Treatment – NCBI Bookshelf”.
Diagnosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Electrocardiogram | Laboratory Findings | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Diagnostic Studies | Other Imaging Findings
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
